V03AC02 • deferiprone • Various | All other therapeutic products | Iron chelating agents
Deferiprone is an iron chelator used for the treatment of chronic iron overload in patients with major thalassemia, particularly when other treatments are not suitable. It works by binding excess iron, facilitating its elimination through urine.
The medication is taken orally, usually three times daily, with the dose adjusted based on the body's iron levels and the patient's weight. Common side effects include nausea, vomiting, joint pain, and neutropenia.
Deferiprone is contraindicated in patients with severe neutropenia, active infections, or hypersensitivity to the active substance. Its use also requires regular monitoring of blood counts to prevent hematological complications.
This medication is an important option for patients with iron overload, helping to reduce the risk of complications associated with this condition.
Substance: deferiprone
Date of last drug list: 01-07-2015
Commercial code: W51518001
Concentration: 500mg
Pharmaceutical form: film-coated tablets
Quantity: 100
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).